SIBN.NASDAQSi-bone, INC

Form 4: SI-BONE Executive Anthony Recupero Awarded Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Anthony Recupero, President of Commercial Operations at SI-BONE, Inc., was granted restricted stock units (RSUs) that will vest over time based on continued service and company performance.

Summary

  • Anthony Recupero, President of Commercial Operations at SI-BONE, Inc., received restricted stock units (RSUs) on February 3, 2025.
  • 55,937 RSUs will vest over four years beginning February 15, 2025, in quarterly installments, contingent upon continued service.
  • An additional 18,646 RSUs will vest over three years based on SI-BONE's total shareholder return (TSR) compared to a peer group.
  • Following these transactions, Recupero beneficially owns 297,397 shares, including 197,488 shares issuable on the settlement of previous RSU grants.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects standard executive compensation practices, aligning management interests with shareholders. The vesting conditions based on TSR suggest a focus on performance.

Positives

  • The grant of RSUs aligns executive compensation with the company's long-term performance and shareholder value.
  • The vesting schedule encourages continued service and commitment from the executive.

Risks

  • The value of the RSUs is dependent on the future performance of SI-BONE's stock.
  • Failure to meet the TSR targets could result in the forfeiture of some or all of the performance-based RSUs.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the RSUs.

Industry Context

Granting stock-based compensation is a common practice in the industry to incentivize executives and align their interests with those of shareholders. The use of TSR-based vesting is also a common method to tie compensation to company performance relative to peers.

Comparison to Industry Standards

  • Many companies in the medical device industry, such as Medtronic, Stryker, and Zimmer Biomet, utilize similar equity-based compensation plans for their executives.
  • The vesting schedules and performance metrics (like TSR) are generally in line with industry standards for executive compensation.

Stakeholder Impact

  • Shareholders may view the RSU grant positively as it aligns executive compensation with company performance.
  • Employees may see it as a positive sign of investment in leadership.

Key Dates

DateDescription
02/03/2025Date of transaction (grant of RSUs)
02/05/2025Date of signature on the Form 4
02/15/2025Start date for vesting of 55,937 RSUs

Keywords

SI-BONE, Anthony Recupero, restricted stock units, RSUs, beneficial ownership, Form 4, executive compensation, total shareholder return, TSR, vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.